Transdermal Maltose-Based Microneedle Patch as Adjunct to Enhance Topical Anesthetic before Intravenous Cannulation

Muhammad Irfan Abdul Jalal1, Kai Shen Ooi2, Kai Cheong Foo2

  • 1UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia.

Journal of Clinical Medicine
|September 23, 2022
PubMed

Insights

Microneedles may improve pain relief for children during IV cannulation. This study tested EMLA cream with dissolvable microneedles to enhance absorption and reduce pain, potentially speeding up the process in busy clinics.

Area of Science:

  • Pediatric Anesthesiology
  • Dermatology
  • Biomaterials Science

Background:

  • Intravenous cannulation causes significant pain and distress in pediatric patients.
  • Topical anesthetics like EMLA (eutectic mixture of local anesthetics) are used, but absorption can be slow and incomplete.
  • Current application times for EMLA may be impractical in fast-paced clinical settings.

Purpose of the Study:

  • To evaluate the efficacy of dissolvable maltose microneedles in enhancing EMLA absorption for pediatric IV cannulation.
  • To compare pain scores and skin conductance using different EMLA concentrations and microneedle application times.
  • To assess the feasibility of microneedle-assisted EMLA for reducing procedural pain in children.

Main Methods:

  • A randomized phase II cross-over trial involving 26 pediatric patients (6-18 years) with thalassemia requiring blood transfusions.
  • Four intervention groups: EMLA with microneedles (1 FTU/30min, 0.5 FTU/30min, 1 FTU/15min) and EMLA with a sham patch (1 FTU/30min).
  • Pain was assessed using Visual Analogue Scale (VAS) scores and skin conductance algesimeter index via PainMonitor™.

Main Results:

  • The study aims to compare pain outcomes between EMLA application with and without microneedle patches.
  • Differences in EMLA dosage and application duration will be analyzed for their impact on pain reduction.
  • Skin conductance will serve as an objective measure of pain perception.

Conclusions:

  • Dissolvable microneedles show promise for improving topical anesthetic efficacy in pediatric procedures.
  • This approach could reduce pain and anxiety associated with IV cannulation.
  • Optimizing EMLA delivery via microneedles may offer a more efficient pain management strategy in pediatric healthcare.

Related Concept Videos

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...